Viatris Inc. (VTRS)
NASDAQ
Closed
Oct 7, 2026
Day's Range
17.4152 wk Range
9.69Overview - VTRS - Viatris Inc.
Key Statistics
Valuation
Enterprise Value
32.32B
P/E (Trailing)
‪235.80‬
P/E (Forward)
‪6.58‬
Price / Sales (TTM)
‪1.37‬
Price / Book
‪1.39‬
EV / EBITDA
‪7.53‬
Profitability
Gross Margin
‪38.76%‬
Profit Margin
‪-2.78%‬
Operating Margin
‪12.55%‬
Return on Assets
‪2.66%‬
Return on Equity
‪-2.75%‬
Ownership
Shares Outstanding
1.15B
Float
1.14B
Short % of Shares Outstanding
‪3.56%‬
Held by Insiders
‪0.31%‬
Held by Institutions
‪93.48%‬
Price stats
Beta
‪0.88‬
50-Day Avg
‪16.94‬
200-Day Avg
‪15.29‬
Dividends
Payout Ratio
‪960.00%‬
Frequency
Quarterly
Analyst Consensus
12 analysts
Average price target
‪$ 18.50‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - VTRS - Viatris Inc.
Peers - VTRS - Viatris Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NASDAQ.
- VTRSNASDAQViatris Inc.20.21BMarket Cap+42.44%52-week change235.80P/E (Trailing)‪-2.78%‬Profit Margin
- NBIXNASDAQNeurocrine Biosciences, Inc.14.55BMarket Cap+2.62%52-week change20.93P/E (Trailing)‪20.91%‬Profit Margin
- AMRXNASDAQAmneal Pharmaceuticals, Inc.7.07BMarket Cap+48.03%52-week change42.29P/E (Trailing)‪5.04%‬Profit Margin
- ALKSNASDAQAlkermes plc7.00BMarket Cap+25.77%52-week change109.87P/E (Trailing)‪3.96%‬Profit Margin
- LNTHNASDAQLantheus Holdings Inc.6.52BMarket Cap+47.28%52-week change23.91P/E (Trailing)‪17.69%‬Profit Margin
- KNSANASDAQKiniksa Pharmaceuticals International, plc Class A Ordinary Shares5.83BMarket Cap+49.48%52-week change76.56P/E (Trailing)‪9.59%‬Profit Margin
- DIODNASDAQDiodes Incorporated4.43BMarket Cap+44.79%52-week change51.08P/E (Trailing)‪5.26%‬Profit Margin
Profile Summary - VTRS - Viatris Inc.
About
Viatris Inc. is a global healthcare company focused on expanding access to a broad range of medicines across multiple therapeutic areas. Its portfolio includes established prescription brands, generic and complex generic medicines, biosimilars, and over-the-counter consumer products that support treatment and disease…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
